Compare RBB & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RBB | CTKB |
|---|---|---|
| Founded | 2008 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 451.0M | 541.1M |
| IPO Year | 2017 | 2021 |
| Metric | RBB | CTKB |
|---|---|---|
| Price | $27.32 | $4.74 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $22.00 | $5.63 |
| AVG Volume (30 Days) | 148.7K | ★ 791.4K |
| Earning Date | 04-20-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.68% | N/A |
| EPS Growth | ★ 24.49 | N/A |
| EPS | ★ 1.25 | N/A |
| Revenue | $5,167,000.00 | ★ $193,015,000.00 |
| Revenue This Year | $20.50 | $5.42 |
| Revenue Next Year | $6.90 | $7.03 |
| P/E Ratio | $22.07 | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $16.74 | $3.28 |
| 52 Week High | $28.24 | $6.18 |
| Indicator | RBB | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 60.48 | 58.18 |
| Support Level | $25.72 | $4.15 |
| Resistance Level | $28.22 | $5.24 |
| Average True Range (ATR) | 0.51 | 0.22 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 81.01 | 73.03 |
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.